Key highlights Lundbeck's total revenue grew by +14% CER[1] (+11% DKK) to DKK 22,004 million in 2024, with all regions contributing to growth United States: DKK 11,325 million (+16% CER; +15% DKK) Eur ...

Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic arthritis, according to data published in Therapeutic Advances in Musculoskeletal ...

Otsuka and Lundbeck’s antidepressant Rexulti should be approved to treat Alzheimer’s disease-related agitation (AAD), according to FDA advisors – a move that could unlock a sizeable new ...

Lundbeck and Otsuka’s Rexulti has become the first drug to be approved by the FDA to treat agitation associated with Alzheimer’s disease, a common symptom of the neurodegenerative disorder.

Therapeutics announced that the U.S. FDA has granted Fast Track designation for rezpegaldesleukin for the treatment of adult and ...

The typical fluoxetine dosage for adults with depression is 20 mg per day. This is typically taken once per day in the morning. After several weeks, your doctor may increase your dose if needed.

Each of the drugs fell three spots from their December seats: Obesity-focused Wegovy took sixth place, while diabetes treatment Ozempic landed in 10th, with $31 million and $14.2 million in ad ...

Nintendo Switch 2 is finally confirmed. After literal years of unverified rumors, dubious leaks and copious amounts of online speculation, Nintendo has lifted the lid on its next-generation ...

Death Stranding 2 has been confirmed for PS5, and Kojima Productions is yet to reveal whether it will arrive on other platforms. When Death Stranding launched in 2019, it did so as a PS4 exclusive.

Regulatory officials have identified 82 cases worldwide from the FDA Adverse Event Reporting System of anaphylaxis associated with the use of Coxapone and the generic Glatopa that have resulted in ...